Bloomberg
@business
The first word in business news | Watch Live: | Newsletters: | Podcasts:
参加 April 2009
104 フォロー中 10.5M ファン
UniQure said that the benefits of its Huntington’s disease gene therapy drug AMT-130 were not as good after four years as they were after three years in a small trial
